Ashwagandha Extract Dosage Guide for Supplement Formulators

Quick-Reference Dosage Table

Use studied	Extract dose in trials	Grade used	Duration
Perceived stress and anxiety, healthy adults	240 mg/day; 250 mg/day; 300 mg twice daily; 600 mg/day	Root extracts standardised on withanolides (1.5% to 5% by HPLC or gravimetry depending on the brand)	8 to 12 weeks (60 days in one trial)
Stress, fatigue and sleep quality	600 mg/day	Root extract, 5% withanolides	8 weeks
Safety monitoring in stressed adults	600 mg/day	Root extract	8 weeks with liver and thyroid panels

The clinically used window is therefore 240 to 600 mg of standardised root extract per day, taken once or split into two doses, for at least eight weeks. Nothing in the trial record supports a claim for a single-day effect, and doses above 600 mg/day have not been studied in the same way.

Withanolide Arithmetic: Why the Percentage Changes the Serving

A 600 mg serving of a 5% withanolide extract delivers about 30 mg of withanolides; the same serving of a 2.5% extract delivers 15 mg, and of a 1.5% extract 9 mg. The trials did not standardise on withanolides delivered, they standardised on the milligrams of a particular branded extract, so the safest way to formulate is to match the extract dose and the grade of the trial you are relying on. A formulator who swaps a 2.5% grade for a 5% grade at the same milligram dose has doubled the withanolide load without a trial behind it; one who halves the dose to keep withanolides constant has left the trial evidence behind in the other direction.

Two further points decide whether the arithmetic holds. First, the assay: a gravimetric 5% and an HPLC 5% are not the same number, as explained in our gravimetric versus HPLC guide. Second, the plant part: the trials above used root extracts, and root and leaf differ in their withanolide profile, particularly in withaferin A. See root versus leaf.

Duration and Onset

Across the stress and anxiety trials, questionnaire scores separated from placebo between weeks four and eight, and the primary endpoints were read at eight to twelve weeks. Label directions should reflect that: a daily dose taken for eight weeks, not a rescue dose. Trials that tested 600 mg/day over eight weeks with laboratory monitoring reported no clinically meaningful change in liver or thyroid markers in healthy adults, which is the most direct safety evidence available at the top of the dose range.

Formulation Notes

• Capsules. A 600 mg/day dose fits one 600 mg vegetable capsule or two of 300 mg; the extract is a fine, hygroscopic brown powder that flows adequately with 0.5 to 1% silica. Bulk density is usually 0.4 to 0.6 g/mL, so a size 0 capsule holds 400 to 500 mg.
• Gummies and beverages. Ashwagandha root extract is bitter and earthy. At 240 to 300 mg per serving it is maskable in a gummy or a flavoured powder; at 600 mg it usually needs a split serving or a debittered grade. Water-dispersible grades exist; check that the withanolide figure is on the same basis as the trial grade.
• Stacking. Trials that combined ashwagandha with other adaptogens or botanicals used the same 300 to 600 mg extract band; do not scale the ashwagandha down because other actives are present.

Safety and Label Considerations

Ashwagandha is not recommended in pregnancy or lactation, and a caution for people with thyroid disorders or on thyroid medication is standard because the extract can raise thyroid hormone levels. Case reports of liver injury exist, most involving multi-ingredient products or undisclosed plant parts; reviews of herb-related liver injury in Indian systems of medicine now list ashwagandha among the herbs to monitor. Some European authorities restrict its use in food supplements pending further assessment, so the destination market must be checked before a product is launched. None of these points changes the dose; they change who should take it and what the label says.

For a supplier-side view of the specification that sits behind a dose, see the COA reading guide and the grade comparison. Trial citations are listed under References.